KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Vertex Pharmaceuticals (VRTX) Cost of Revenue (2016 - 2025)

Vertex Pharmaceuticals has reported Cost of Revenue over the past 15 years, most recently at $466.0 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $466.0 million for Q4 2025, up 10.06% from a year ago — trailing twelve months through Dec 2025 was $1.7 billion (up 7.89% YoY), and the annual figure for FY2025 was $1.7 billion, up 7.89%.
  • Cost of Revenue for Q4 2025 was $466.0 million at Vertex Pharmaceuticals, up from $414.8 million in the prior quarter.
  • Over the last five years, Cost of Revenue for VRTX hit a ceiling of $466.0 million in Q4 2025 and a floor of $192.3 million in Q1 2021.
  • Median Cost of Revenue over the past 5 years was $313.6 million (2023), compared with a mean of $321.4 million.
  • Biggest five-year swings in Cost of Revenue: grew 29.9% in 2023 and later grew 5.65% in 2025.
  • Vertex Pharmaceuticals' Cost of Revenue stood at $247.4 million in 2021, then grew by 14.51% to $283.3 million in 2022, then grew by 29.9% to $368.0 million in 2023, then increased by 15.05% to $423.4 million in 2024, then increased by 10.06% to $466.0 million in 2025.
  • The last three reported values for Cost of Revenue were $466.0 million (Q4 2025), $414.8 million (Q3 2025), and $407.5 million (Q2 2025) per Business Quant data.